Biotech · Private company
Zogenix, Inc.
Track this companyFree. Adds Zogenix, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials91 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- FenfluraminePhase 3 · CDKL5 Deficiency DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Hydrocodone bitartratePhase 3 · Back Pain Lower Back ChronicClinicalTrials.gov · fetched Nov 12, 2026
- Hydrocodone BitartratePhase 3 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
- ZX008 (Fenfluramine Hydrochloride)Phase 3 · Dravet SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Intraject SumatriptanPhase 2 · Migraine HeadacheClinicalTrials.gov · fetched Nov 12, 2026
- Oral RisperidonePhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Risperdal ConstaPhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- risperidone-SABERPhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- Sumatriptan (via Intraject System)Phase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- ZX003 (Risperidone-SABER®)Phase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- ZX003:risperidone-SABER and the DosePro SystemPhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- SumatriptanMigraineClinicalTrials.gov · fetched Nov 12, 2026
- Sumavel DoseProMigraineClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.PHASE3 · ACTIVE_NOT_RECRUITING · started Mar 8, 2022ClinicalTrials.gov NCT05064878 · fetched Nov 12, 2026
- A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut SyndromePHASE3 · COMPLETED · started Apr 22, 2019ClinicalTrials.gov NCT03936777 · fetched Nov 12, 2026
- Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable SchizophreniaPHASE1 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02411526 · fetched Nov 12, 2026
- A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With SchizophreniaPHASE1 · COMPLETED · started Jul 1, 2012ClinicalTrials.gov NCT01592110 · fetched Nov 12, 2026
- Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic PainPHASE3 · COMPLETED · started May 1, 2010ClinicalTrials.gov NCT01115569 · fetched Nov 12, 2026
- Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back PainPHASE3 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01081912 · fetched Nov 12, 2026
- Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of MigrainePHASE4 · COMPLETED · started Nov 30, 2009ClinicalTrials.gov NCT01016834 · fetched Nov 12, 2026
- A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine AttackPHASE2 · COMPLETED · started Sep 1, 2007ClinicalTrials.gov NCT00530517 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject SystemPHASE1 · COMPLETED · started Dec 1, 2006ClinicalTrials.gov NCT00614029 · fetched Nov 12, 2026